The Top Line cover image

Bayer’s collaborative model: Breaking silos to accelerate impact (Sponsored)

The Top Line

00:00

How Bayer chooses assets to commercialize

Christine and Dr. Wahdan explain focusing on unmet medical need, core strengths, targeted tumor areas, platform companies, and AI-driven discovery.

Play episode from 20:42
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app